Proton Therapy
Charged-particle radiotherapy using accelerated protons instead of MV X-rays. Physics advantage: protons deposit most of their energy at a specific depth (the Bragg peak) with minimal exit dose beyond. This allows sparing of critical structures distal to the tumor in ways X-ray beams cannot.
Multi-hundred-million-dollar capital projects. Cyclotron or synchrotron accelerator + beam transport + treatment room gantries + treatment planning systems.
Physics
- Protons accelerated to clinical energies (70–250 MeV) by a cyclotron or synchrotron
- Beam delivery — range modulation + spread-out Bragg peak to cover target depth, lateral scanning or passive scattering to cover target breadth
- Two delivery approaches:
- Passive scattering — older, simpler, uses physical scattering + compensators + apertures
- Pencil Beam Scanning (PBS) — modern, uses magnetic steering of a narrow pencil beam spot-by-spot, depth-by-depth. Enables IMPT (intensity-modulated proton therapy), analog of IMRT but for protons
Clinical indications
- Pediatric CNS tumors — strongest evidence base. Reducing integral brain dose to young patients has meaningful long-term outcome benefit.
- Chordoma + chondrosarcoma — skull base, spine. Proton's depth precision matters near brainstem + cord.
- Hepatocellular carcinoma — sparing of cirrhotic liver
- Head and neck — sparing of salivary + oral mucosa
- Breast — particularly left-breast (cardiac sparing)
- Prostate — debated. Reasonable outcomes but cost-effectiveness questioned vs modern IMRT/VMAT
- Re-irradiation — prior dose limits photon options
Vendors + systems
- IBA — Proteus ONE (compact single-room), Proteus PLUS (multi-room)
- Hitachi Proton Beam Therapy System
- Varian ProBeam (IBA licensee + independent Varian offering)
- Mevion S250 (single-room superconducting synchrocyclotron)
- Sumitomo Heavy Industries (Japan)
Install reality
- Capital cost: $25M (single-room compact) to $200M+ (multi-room full center)
- Site prep: years. Concrete bunkers, cyclotron vault, beam-transport tunnels, multiple gantry rooms
- Staffing: physicists + therapists + engineers + cyclotron operators — more specialized than conventional rad onc
- Patient volume: proton centers run at specific capacity; multi-room centers treat 40–120+ patients/day
Market reality
Proton therapy is clinically valuable for a narrow set of indications (pediatric CNS, chordoma, specific anatomic cases) and debated for broader adoption. Centers built on broad-indication hopes have struggled financially when real indication volumes fell short of models. Compact single-room systems (Proteus ONE, Mevion) lowered the capital barrier and enabled hospital-scale entry.